Compare BKH & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BKH | TFX |
|---|---|---|
| Founded | 1941 | 1943 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 5.8B |
| IPO Year | 2001 | 1994 |
| Metric | BKH | TFX |
|---|---|---|
| Price | $78.44 | $129.71 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 13 |
| Target Price | $84.86 | ★ $154.00 |
| AVG Volume (30 Days) | ★ 1.3M | 705.6K |
| Earning Date | 11-04-2026 | 11-05-2026 |
| Dividend Yield | ★ 3.63% | 1.04% |
| EPS Growth | ★ 1.79 | N/A |
| EPS | ★ 2.23 | 2.08 |
| Revenue | ★ $2,310,000,000.00 | $1,992,713,000.00 |
| Revenue This Year | $6.29 | $13.82 |
| Revenue Next Year | $50.01 | $4.32 |
| P/E Ratio | ★ $34.83 | $62.57 |
| Revenue Growth | ★ 8.57 | N/A |
| 52 Week Low | $62.27 | $100.18 |
| 52 Week High | $78.69 | $145.00 |
| Indicator | BKH | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 68.75 | 54.82 |
| Support Level | $71.26 | $129.65 |
| Resistance Level | $78.33 | $137.48 |
| Average True Range (ATR) | 1.75 | 2.96 |
| MACD | 0.46 | 1.06 |
| Stochastic Oscillator | 97.37 | 75.32 |
Black Hills Corp is a U.S.-based energy company that operates through its Electric Utilities and Gas Utilities segment. These segments operate in states in the Midwest and mountain regions in the U.S. The company's customers include residential, commercial, industrial, and municipal consumers. These customers are residential. Black Hills derives the majority of its revenue from its utility business group, specifically from gas utilities.
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.